Biotechnology & Biotechnological Equipment
Volume 38, 2024 - Issue 1
Research Article
Can EBP50 and Merlin be used as diagnostic and prognostic markers for uterine smooth muscle tumors?
Ulaş Alabalika Department of Pathology, Medical Faculty, Dicle University, Diyarbakir, TurkeyCorrespondence[email protected]
https://orcid.org/0000-0003-4551-8439View further author information
https://orcid.org/0000-0003-4551-8439View further author information, Ayşe Nur Keleşa Department of Pathology, Medical Faculty, Dicle University, Diyarbakir, Turkeyhttps://orcid.org/0000-0003-2617-2591View further author information
https://orcid.org/0000-0003-2617-2591View further author information, Reyhan Gündüzb Department of Obstetrics and Gynecology, Medical Faculty, Dicle University, Diyarbakir, Turkeyhttps://orcid.org/0000-0001-8468-7038View further author information
https://orcid.org/0000-0001-8468-7038View further author information, Zuhat Urakçıc Department of Medical Oncology, Medical Faculty, Dicle University, Diyarbakir, Turkeyhttps://orcid.org/0000-0003-3878-988XView further author information
https://orcid.org/0000-0003-3878-988XView further author information & İsmail Yıldızd Department of Biostatistics, Medical Faculty, Dicle University, Diyarbakir, Turkeyhttps://orcid.org/0000-0001-5505-838XView further author information
https://orcid.org/0000-0001-5505-838XView further author information